Cedar Mountain Advisors’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$6.53K Sell
28
-5
-15% -$1.16K ﹤0.01% 576
2026
Q2
$6.99K Hold
33
– – ﹤0.01% 595
2026
Q1
$6.47K Hold
33
– – ﹤0.01% 574
2025
Q4
$5.73K Hold
33
– – ﹤0.01% 304
2025
Q3
$6.29K Hold
33
– – ﹤0.01% 308
2025
Q2
$5.93K Sell
33
-28
-46% -$4.86K ﹤0.01% 256
2025
Q1
$10.3K Hold
61
– – ﹤0.01% 203
2024
Q4
$9.2K Hold
61
– – ﹤0.01% 210
2024
Q3
$9.47K Hold
61
– – ﹤0.01% 203
2024
Q2
$8.35K Hold
61
– – ﹤0.01% 199
2024
Q1
$8.12K Hold
61
– – ﹤0.01% 200
2023
Q4
$8.41K Buy
61
+29
+91% +$3.81K ﹤0.01% 193
2023
Q3
$3.9K Hold
32
– – ﹤0.01% 226
2023
Q2
$4.5K Hold
32
– – ﹤0.01% 210
2023
Q1
$4.53K Sell
32
-10
-24% -$1.43K ﹤0.01% 212
2022
Q4
$6.57K Hold
42
– – ﹤0.01% 188
2022
Q3
$5K Hold
42
– – ﹤0.01% 208
2022
Q2
$6K Hold
42
– – ﹤0.01% 202
2022
Q1
$6K Hold
42
– – ﹤0.01% 220
2021
Q4
$7K Sell
42
-2
-5% -$304 ﹤0.01% 210
2021
Q3
$6K Hold
44
– – ﹤0.01% 219
2021
Q2
$6K Hold
44
– – ﹤0.01% 202
2021
Q1
$6K Hold
44
– – ﹤0.01% 207
2020
Q4
$5K Sell
44
-36
-45% -$4.39K ﹤0.01% 207
2020
Q3
$9K Buy
80
+20
+33% +$2.36K ﹤0.01% 165
2020
Q2
$7K Hold
60
– – ﹤0.01% 169
2020
Q1
$5K Hold
60
– – ﹤0.01% 157
2019
Q4
$6K Buy
+60
New +$6.26K ﹤0.01% 164

Other funds holding DGX

Cedar Mountain Advisors's DGX Position: Q3 2026 in Review

Cedar Mountain Advisors reduced its Quest Diagnostics (DGX) stake by 15% in Q3 2026, selling an estimated $1.16K and leaving 28 shares worth $6.53K. The position accounts for ﹤0.01% of the portfolio, ranked #576.

Cedar Mountain Advisors first reported a position in DGX in Q4 2019 and has held it in 28 quarters since. The position peaked at $10.3K in Q1 2025. 266 funds tracked by Wall St. Rank hold DGX as of Q3 2026.

  • Cedar Mountain Advisors held 28 shares of Quest Diagnostics worth $6.53K as of Q3 2026.
  • Cedar Mountain Advisors sold 5 Quest Diagnostics shares in Q3 2026, an estimated $1.16K.
  • Quest Diagnostics made up ﹤0.01% of Cedar Mountain Advisors's portfolio in Q3 2026, its #576 holding.
  • Cedar Mountain Advisors first reported a position in Quest Diagnostics in Q4 2019 and has held it in 28 quarters since.
  • Cedar Mountain Advisors's Quest Diagnostics position peaked at $10.3K in Q1 2025.
  • 266 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2026.

Based on Cedar Mountain Advisors's 13F filing for Q3 2026, filed 15 Oct 2026.